Reports: Aptahems delårsrapport 2021-07-01 till 2021-09-30

Press release from Companies: Aptahem har startat produktionen av GMP-certifierad Apta-1 inför kliniska prövningar

Press release from Companies: Aptahem has started the production of GMP certified Apta-1 for clinical trials

Press release from Companies: Aptahem announces positive biological effect in a Corona virus-induced acute lung injury model treated with Apta-1

Press release from Companies: Aptahem meddelar positiva biologiska effekter i en coronavirus-orsakad lungskademodell med behandling av Apta-1

Market Notices: Market Notice 209/21 Information regarding Aptahem AB’s subscription options

Press release from Companies: Aptahem offentliggör utfall i inlösen av teckningsoptioner serie TO 6

Market Notices: Market Notice 204/21 - Last day of trading in Aptahem AB’s BTU

Press release from Companies: Aptahem meddelar sista dag för handel med BTU och första handelsdag för teckningsoptioner serie TO 7

Press release from Companies: Aptahem receives Turkish patent for the protection of patent family 2

Press release from Companies: Aptahem erhåller patent i Turkiet för skydd av patentfamilj 2

Market Notices: Market Notice 194/21– Last day of trading in Aptahem AB’s subscription option APTA TO 6